President Donald Trump has instructed federal agencies and their assigned DOGE teams to repeal any existing regulations that are inconsistent with his priorities without providing advance notice or ...

Privacy World reported on the Federal Communications Commission’s (“FCC” or “Commission”) clarification and codification of ...

CEO Stephen Glover said, “ZyVersa is developing Cholesterol Efflux Mediator VAR 200 for treatment of chronic kidney diseases, initially ...

On March 26, 2025, the Company announced that the U.S. Food and Drug Administration (FDA) issued an Approvable Letter regarding the Company's Pre-Market Approval (PMA) application for the Genio® ...